The India-US joint statement highlights the provisional exclusion of Indian pharmaceutical exports comprising generic drugs including antibiotics, vaccines, bulk drugs and intermediates, from reciprocal tariffs but it is subject to the successful conclusion of the interim agreement
​The India-US joint statement highlights the provisional exclusion of Indian pharmaceutical exports comprising generic drugs including antibiotics, vaccines, bulk drugs and intermediates, from reciprocal tariffs but it is subject to the successful conclusion of the interim agreement by Soban News (international And National News)
